|
Status |
Public on Apr 26, 2022 |
Title |
MN_T0_CRISPR |
Sample type |
SRA |
|
|
Source name |
MLL-AF9; KrasG12D cell line
|
Organism |
Mus musculus |
Characteristics |
cell type: MN AML cells treatment: Untreated time point: 0 day
|
Treatment protocol |
AG636 was refreshed every 2-3 days. 2 x 10^6 live cells was harvested at every time point.
|
Growth protocol |
MN cells tumor cells were cultured in Anne-Kelso DMEM supplemented with 20% foetal calf serum, 0.1mM L-asparagine, 100 U/mL penicillin, 100 mg/mL streptomycin, at 37°C and 10% CO2.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was extracted from cells using DNeasy Blood & Tissue Kit (Qiagen). Sequencing libraries were prepared by nested PCR method to amplify integrated CRISPR guides.
|
|
|
Library strategy |
OTHER |
Library source |
genomic |
Library selection |
other |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
AG636_CRISPRscreenCounts_normalised.txt
|
Data processing |
The RNA sequencing reads were trimmed using cutadapt (v1.16.5) to remove poor quality ends. The resulting reads were aligned and statistical significance was calculated using MAGeCK algorithm (v0.5.8.1). Genome_build: mm10 (GRCm38) Supplementary_files_format_and_content: AG636_CRISPRscreenCounts_normalised.txt: Normalized count file representing number of reads per guide scored in T0, T10 and T24 samples.
|
|
|
Submission date |
Aug 08, 2021 |
Last update date |
Apr 26, 2022 |
Contact name |
Joan So |
E-mail(s) |
[email protected]
|
Organization name |
Peter MacCallum Cancer Centre
|
Street address |
305 Grattan St
|
City |
Melbourne |
State/province |
Victoria |
ZIP/Postal code |
3000 |
Country |
Australia |
|
|
Platform ID |
GPL19057 |
Series (2) |
GSE181665 |
Inhibition of pyrimidine biosynthesis targets protein translation in AML [Targeted_CRISPR_screen] |
GSE181666 |
Inhibition of pyrimidine biosynthesis targets protein translation in AML |
|
Relations |
BioSample |
SAMN20667419 |
SRA |
SRX11672750 |